Affordable Access

Induction doses of interferon-alpha-2a in combination with ribavirin and/or amantadine for the treatment of chronic hepatitis C in non-responders to interferon monotherapy: a randomized trial.

Authors
Type
Published Article
Journal
Journal of viral hepatitis
Publication Date
Volume
14
Issue
2
Pages
89–95
Identifiers
PMID: 17244248
Source
Medline

Abstract

Statistics

Seen <100 times